Subscribe To
Black diamond therapeutics presents dose escalation data demonstrating durable responses in patients with nsclc from phase 1 trial of bdtx-1535
Initial results from BDTX-1535 dose escalation show durable activity in patients with NSCLC across heterogeneous EGFR mutation subtypes No new safety ...
October 14, 2023, 4:30 pm
Cogent biosciences presents preclinical data highlighting precision oncology pipeline at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
– Novel selective and reversible FGFR2 inhibitor exhibits strong potency across key primary and resistance driver mutations with potential advantage...
October 14, 2023, 4:30 pm
Prelude announces multiple clinical and preclinical poster presentations at aacr-nci-eortc international conference
WILMINGTON, Del. and BOSTON, Oct. 14, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD), a clinical-stage pre...
October 14, 2023, 4:30 pm
Mid-october 2023 watchlist: leading ancillary cannabis stocks
The cannabis industry's landscape is still changing at an incredibly fast rate as we approach mid-October 2023. The ancillary business has become a ho...
October 14, 2023, 3:00 pm
Morphic holding shareholder alert: johnson fistel encourages morphic holding shareholders with losses to contact the firm regarding investigation
SAN DIEGO, Oct. 13, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether Morphic...
October 13, 2023, 11:51 pm
Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsenta...
October 13, 2023, 8:30 pm
Stronghold announces bitcoin mining update and frontier managed services agreement
NEW YORK, Oct. 13, 2023 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, or the “Company”) today provided th...
October 13, 2023, 8:30 pm
Mineralys therapeutics announces upcoming poster presentations at two scientific conferences in november 2023
Late-breaking poster presentation at ASN’s Kidney Week 2023 – – –Poster presentation at AHA’s Scientific Sessions 2023 RADNOR, Pa., Oct. 13,...
October 13, 2023, 8:10 pm
Graphic packaging (gpk) ascends while market falls: some facts to note
The latest trading day saw Graphic Packaging (GPK) settling at $20.93, representing a +0.34% change from its previous close....
October 13, 2023, 7:33 pm
Nokia (nok) suffers a larger drop than the general market: key insights
The latest trading day saw Nokia (NOK) settling at $3.51, representing a -1.68% change from its previous close....
October 13, 2023, 7:32 pm
Why rockwell medical (rmti) dipped more than broader market today
The latest trading day saw Rockwell Medical (RMTI) settling at $1.97, representing a -0.51% change from its previous close....
October 13, 2023, 7:32 pm
Alnylam pharmaceuticals: a good buy ahead of phase 3 data for vutrisiran
We rate Alnylam Pharmaceuticals, Inc.'s common stock a Buy on the dip after the complete response letter, CRL for Patisiran. The investment thesis is ...
October 13, 2023, 6:11 pm
Processa pharmaceuticals to present at the thinkequity conference
HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ...
October 13, 2023, 5:08 pm
Kronos bio presents positive preliminary data from phase 1 dose escalation portion of phase 1/2 kb-0742 study at aacr-nci-eortc
Demonstrated on-mechanism, single agent anti-tumor activity in heavily pre-treated patients with transcriptionally addicted solid tumors Showed manage...
October 13, 2023, 4:30 pm
Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023
Two late-breaking high-impact oral presentations of the Phase 3 PROTECT Study of FILSPARI ® (sparsentan) in IgAN and Phase 3 DUPLEX Study of sparsent...
October 13, 2023, 4:30 pm
Canada goose: undervalued luxury
Luxury conglomerates are struggling with demand overhang as consumers pulled forward purchases into the pandemic period. Canada Goose stock has declin...
October 13, 2023, 4:29 pm
Revolution medicines presents encouraging clinical data for rmc-6236 and rmc-6291 at 2023 triple meeting
Clinical dose escalation data for RMC-6236, a RASMULTI(ON) Inhibitor, show oral bioavailability, well-tolerated safety profile and preliminary evidenc...
October 13, 2023, 3:50 pm
Weyerhaeuser and west fraser lead the pack in timber/lumber
Timber REITs are trading at discounts to their asset value, presenting buying opportunities. Investment in timber REITs involves different segments wi...
October 13, 2023, 2:51 pm
Vera therapeutics to present three posters at the american society of nephrology kidney week 2023 annual meeting
Informational poster for ORIGIN 3 Pivotal Phase 3 study evaluating atacicept in IgA Nephropathy (IgAN) Additional analysis of week 36 data from Phase ...
October 13, 2023, 2:22 pm
Outsmart the market with these 3 ai picks-and-shovels stocks
Every emerging sector has its picks-and-shovels stocks that represent the crucial tools and equipment n...
October 13, 2023, 1:50 pm